Keywords: AstraZeneca, Abbott, Certraid, FDA, Cholesterol lowerer, TriLipix

AstraZeneca/Abbott’s combo cholesterol drug Certraid in doubt after FDA calls for more information

Article | 31 March 2010

Print This

Anglo-Swedish drug major AstraZeneca and the USA’s Abbott Laboratories announced yesterday that the US Food and Drug Administration issued ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in